The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

Page 39 of 100

A measure of immune age? Recently published in Nature Medicine

It is well established that the immune response decreases with aging. With this, we observe a moderate increase in circulating inflammatory mediators, known as “inflamm-aging”. However, the dynamics of the immune loss process, at the individual level, has not been… Continue Reading →

Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: an EU/US CTAD Task Force Report

There is an urgent need to develop reliable and sensitive bloodbased biomarkers of Alzheimer’s disease (AD) that can be used for screening and to increase the efficiency of clinical trials. The European Union-North American Clinical Trials in Alzheimer’s Disease Task… Continue Reading →

Combination Therapy for Alzheimer’s Disease: Perspectives of the EU/ US CTAD Task Force

Combination therapy is expected to play an important role for the treatment of Alzheimer’s disease (AD). In October 2018, the European Union-North American Clinical Trials in Alzheimer’s Disease Task Force (EU/US CTAD Task Force) met to discuss scientific, regulatory, and… Continue Reading →

« Older posts Newer posts »

© 2025 Aging-news